1. Home
  2. TLIH vs CANF Comparison

TLIH vs CANF Comparison

Compare TLIH & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLIH

Ten-League International Holdings Limited Ordinary Shares

N/A

Current Price

$4.60

Market Cap

12.9M

Sector

N/A

ML Signal

N/A

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$2.67

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLIH
CANF
Founded
1998
1994
Country
Singapore
Israel
Employees
70
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
6.0M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
TLIH
CANF
Price
$4.60
$2.67
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$50.00
AVG Volume (30 Days)
13.4K
27.6K
Earning Date
05-01-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2,715,455.50
Revenue Next Year
N/A
$101.06
P/E Ratio
$3.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.17
52 Week High
$7.00
$10.40

Technical Indicators

Market Signals
Indicator
TLIH
CANF
Relative Strength Index (RSI) 67.05 31.86
Support Level $0.32 $0.22
Resistance Level N/A $3.24
Average True Range (ATR) 0.34 0.23
MACD -0.05 -0.01
Stochastic Oscillator 97.09 7.53

Price Performance

Historical Comparison
TLIH
CANF

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental, and provision of engineering consultancy services to port, construction, civil engineering, and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment, and port machinery. The company operates in Singapore and Other international countries.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: